Topical Timolol for Superficial Infantile Hemangioma
NCT01685398
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Hemangioma
Interventions
DRUG:
0.5% timolol maleate eye drop
DRUG:
Normal saline
Sponsor
Mahidol University